Latest Morning Briefing Stories
El alto precio de la insulina lleva a que pacientes la racionen, a riesgo de muerte
El precio de la insulina en los Estados Unidos aumentó más del doble desde 2012. Eso pone a la hormona que salva vidas fuera del alcance de algunas personas con diabetes.
Insulin’s Steep Price Leads To Deadly Rationing
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The Doctors Want In: Democratic Docs Talk Health Care On The Campaign Trail
Among candidates running for Congress in upcoming elections are a smattering of left-leaning physicians who present a stark contrast to the predominantly Republican physicians currently in office.
Could California Shape The Fate Of The Affordable Care Act In November?
With the primary now over, health care may well emerge as an issue that helps voters distinguish between candidates for governor, attorney general and other offices in the general election.
Desafío médico y moral: tratar a pacientes indocumentados con enfermedad renal terminal
Se estima que, en los Estados Unidos, hay 6.500 inmigrantes indocumentados con enfermedad renal en etapa terminal. Muchos de ellos terminan recibiendo diálisis en salas de emergencias.
Another Cause Of Doctor Burnout: Being Forced To Give Immigrants Unequal Care
Undocumented patients with kidney disease often can’t get treatment unless they are in a state of emergency. This bothers clinicians who want to treat all patients equally.
Podcast: KHN’s ‘What The Health?’ Campaign Promises Kept, Plus ‘Nerd Reports’
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHN’s Liz Szabo about the May “Bill of the Month.”
Trump Proposes Cutting Planned Parenthood Funds. What Does That Mean?
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
Indocumentada y con cáncer: entre la muerte y la deportación
¿Qué sucede cuando un inmigrante indocumentado tiene un diagnóstico potencialmente mortal? Depende mucho de en dónde viva.
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Por qué Trump quiere quitarle fondos a Planned Parenthood
La reactivación de una norma que data de la presidencia de Ronald Reagan podría ayudar al presidente a cumplir su promesa de campaña de “cancelar” Planned Parenthood.
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
L.A. County Unlawfully Terminated Thousands Of Medi-Cal Recipients, Court Rules
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
Podcast: KHN’s ‘What The Health?’ Medicaid, Privacy And Tom Price’s Return
Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Talking Points Memo discuss the latest on states’ efforts to reshape their Medicaid programs, the kerfuffle over President Donald Trump’s medical records and comments by former Health and Human Services Secretary Tom Price about Congress’ repeal of the Affordable Care Act’s “individual mandate” penalty. Rovner also interviews Harvard professor Robert Blendon about the complex politics of health in the coming midterm elections.
Must-Reads Of The Week From Brianna Labuskes
Happy Friday! Welcome to the inaugural edition of KHN’s Friday Breeze. As the newsletter editor at Kaiser Health News, I read hundreds of health stories a week, and I’m here each Friday to sum up the more important ones — interesting reads, news that will have lasting impact, unique takes on the big problems in the […]
¡Cuidado! La multa por no tener seguro que impuso el Obamacare todavía está vigente
Si bien la administración Trump derogó la multa por no tener seguro de salud que impuso la Ley de Cuidado de Salud Asequible, esta norma entrará en vigencia en 2019.
Ding Dong! The Obamacare Tax Penalty Is(n’t) Dead
When President Donald Trump signed the nation’s new tax law, he also killed the Affordable Care Act’s tax penalty — but not until 2019. Despite widespread confusion, experts caution that consumers still need to pay the tax penalty if they were uninsured last year or will be this year.
Pobres y sin atención médica: la nueva realidad de los suburbios
Siempre se creyó que era un enclave de los ricos, pero hoy en día más de 17 millones de personas viven en los suburbios, en donde es un desafío encontrar un doctor.
